 |
|
| CHAIRMAN, IVIVI SCIENTIFIC ADVISORY BOARD |
Dr. Arthur Pilla
|
Dr. Arthur Pilla, Chairman, Ivivi Scientific Advisory Board received his Ph.D., cum laude, from the University of Paris, France in 1964. Professor Emeritus, Department of Orthopedics Mount Sinai School of Medicine, NY and Professor, Department of Biomedical Engineering, Columbia University, NY.
- Dr Pilla commenced studies of the bioeffects of weak magnetic and electric fields in 1969. His electrochemical information transfer model (1972) led to the invention of the first bone-growth electromagnetic stimulator device for clinical use.
- Cofounder of Electrobiology, Inc. ("EBI"), now part of Biomet. EBI's IPO was a model at the time and established Dr. Pilla as a major player in the development of magnetic and electric field devices for therapeutic applications. Bone repair, using devices based on Dr. Pilla's research and inventions, is currently a $450 million industry in the US.
- His award-winning rabbit bone repair model, which was completely tracked by human clinical data, played a major role in achieving the first FDA clearance for the acceleration of fresh fracture repair with weak ultrasound. Dr. Pilla's contributions played a key role in the successful search for venture capital and corporate funding for the emerging ultrasound bone repair industry. Smith & Nephew, a major player in the orthopedic device industry, acquired this technology in late 1999 and they now hold 25% of the difficult-to-heal fracture market.
- Dr. Pilla has developed and patented pulsed radio frequency signals for use in the physical therapy of wound repair and pain relief.
- Co-Author of several professional books in Bioelectromagnetics and Electrochemistry, he has been chairman of over 25 Professional Society symposia worldwide.
- Author of over 200 medical/scientific publications in the science of bioelectromagnetic wound healing, tissue repair, osteointegration, treatment of non-unions.
- Has received many awards and honors in his field.
|
|
|
|
|
|
|
